• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy American Health Care Consumers Should Have Access to Drugs and Devices Benefitting People in Developed Countries
Economy

American Health Care Consumers Should Have Access to Drugs and Devices Benefitting People in Developed Countries

by December 3, 2022
by December 3, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp
Reprinted from the Cato Institute

Swiss Medtech, a trade association representing the medical technology industry, issued a press release on November 28 praising the Swiss Parliament for enacting legislation allowing Swiss health care providers and patients to access medical devices approved by the U.S. Food and Drug Administration. Until now, the Swiss government only permitted patients and doctors to access devices that have a CE Marking, which indicates the device meets European Union standards, and the E.U. approves it for marketing among member states. The Swiss Parliament’s action should expand access and increase price competition for medical devices.

Australia began permitting patients and doctors to access FDA‐​approved medical devices in 2018 and has been allowing them to use E.U.-approved devices for several years. Israel allows devices approved in the U.S., E.U., Australia, and Canada.

U.S. lawmakers have proposed legislation permitting American health care consumers and providers to access drugs and/​or devices approved in other developed countries. Policymakers inaptly refer to the proposal as “reciprocity,” but the reform is not contingent upon the other countries permitting their residents to use FDA‐​approved drugs or devices in return.

In testimony before the Joint Economic Committee in September 2020, I stated:

Congress should pass legislation giving reciprocal approval to drugs and medical devices (which includes tests) in similar countries. Reciprocal approval already exists among the European Union states plus Iceland, Liechtenstein, and Norway. In July 2019 Senator Ted Cruz (R‑TX) introduced S.2161, the Reciprocity Ensures Streamlined Use of Lifesaving Treatment (RESULT) Act, which would allow for the marketing of drugs approved in certain countries, but not yet approved by the FDA, if “there is an unmet need.” While this is indeed a step in the right direction, in the interest of promoting competition and consumer choice, reciprocal approval should not be contingent on an unmet need.

In Drug Reformation, published later that year, Michael F. Cannon and I wrote:

…at a minimum Congress should eliminate the FDA’s ability to restrict truthful speech by manufacturers about their products and allow American consumers to purchase drugs that have won approval from designated certification agencies, including foreign regulatory bodies. According to one study, recognizing drug approvals by regulatory bodies in Canada and Europe between 2000 and 2010 would have given U.S. consumers quicker access to 37 “novel” drugs for which “no other FDA‐​approved prescription medicine had the same mechanism of action,” including 10 drugs treating mostly orphan diseases “for which no alternative therapy was available in the USA.” Such recognition would have allowed U.S. consumers to access those drugs a median of 13.6 months earlier.

If members of the incoming Congress are serious about increasing access to health care and reducing health care costs, they should, at a minimum, pass a law that allows for drug and device “reciprocity” with other developed nations.

You Might Also Like
  • Ohio train derailment: Rep. Omar calls out Buttigieg for ‘direct action,’ Vance says ‘many questions remain’
  • Biden used CPAP machine for sleep apnea, explaining face marks
  • Soaring popularity of Vance’s ‘Hillbilly Elegy’ rebuts narrative that Trump VP pick is floundering
  • House GOP campaign arm blasts rhetoric of Dems for fueling ‘Jewish hate’: ‘Cause and effect’
Share
0
FacebookTwitterPinterestWhatsapp

previous post
What Role Does Knowledge Management Play in an Organization?
next post
The case for investing in REITs despite the Blackstone news

You may also like

RFK Jr scores endorsements from 3 high-profile athletes

November 14, 2023

State Department’s Afghanistan withdrawal review blames Trump, Biden administrations: ‘Painful...

July 1, 2023

Campaign chairs say Biden is both ‘more committed than ever’...

July 19, 2024

NYPD commish admits ‘people taking advantage’ of bail reform, laments...

April 17, 2023

Texas Gov. Abbott touts new border wall construction, amid Biden...

September 14, 2023

Biden says ‘The choice is up to you, the American...

July 25, 2024

Mike Pompeo suggests Trump wasn’t ‘true conservative leader’ for his...

March 6, 2023

Harris to name VP by next week, kick off battleground...

July 30, 2024

Minnesota Rep. Angie Craig credits morning coffee after DC elevator...

February 11, 2023

Border Patrol forced to keep migrants outdoors in Arizona desert...

August 6, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • From Oversold to Opportunity: Small Caps on the Move

      July 3, 2025
    • Money’s Not Leaving the Market — It’s Rotating!

      July 3, 2025
    • Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

      July 3, 2025
    • Microsoft laying off about 9,000 employees in latest round of cuts

      July 3, 2025
    • Missed Disney’s Rally? Grab This Defined-Risk Put Spread for a Second Chance

      July 2, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,628 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,910 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,601 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,566 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,442 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,162)
    • Investing (538)
    • Stock (2,652)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • From Oversold to Opportunity: Small Caps on the Move

      July 3, 2025
    • Money’s Not Leaving the Market — It’s Rotating!

      July 3, 2025
    • Tariffs and weaker beer demand are weighing on Modelo owner...

      July 3, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,162)
    • Investing (538)
    • Stock (2,652)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Texas AG Paxton acquitted on all...

    September 17, 2023

    Rubio warns Chinese cyberattack ‘will be...

    February 23, 2024

    Israel vows to kill new Hamas...

    August 7, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here